Literature DB >> 22575479

Organ size control by Hippo and TOR pathways.

Karen Tumaneng1, Ryan C Russell, Kun-Liang Guan.   

Abstract

The determination of final organ size is a highly coordinated and complex process that relies on the precise regulation of cell number and/or cell size. Perturbation of organ size control contributes to many human diseases, including hypertrophy, degenerative diseases, and cancer. Hippo and TOR are among the key signaling pathways involved in the regulation of organ size through their respective functions in the regulation of cell number and cell size. Here, we review the general mechanisms that regulate organ growth, describe how Hippo and TOR control key aspects of growth, and discuss recent findings that highlight a possible coordination between Hippo and TOR in organ size regulation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22575479      PMCID: PMC3601681          DOI: 10.1016/j.cub.2012.03.003

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  166 in total

1.  Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver.

Authors:  Ben Z Stanger; Akemi J Tanaka; Douglas A Melton
Journal:  Nature       Date:  2007-01-28       Impact factor: 49.962

2.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.

Authors:  Emilie Vander Haar; Seong-Il Lee; Sricharan Bandhakavi; Timothy J Griffin; Do-Hyung Kim
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

3.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

Review 4.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

5.  Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.

Authors:  J Heitman; N R Movva; M N Hall
Journal:  Science       Date:  1991-08-23       Impact factor: 47.728

6.  TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

Authors:  Ken Inoki; Hongjiao Ouyang; Tianqing Zhu; Charlotta Lindvall; Yian Wang; Xiaojie Zhang; Qian Yang; Christina Bennett; Yuko Harada; Kryn Stankunas; Cun-Yu Wang; Xi He; Ormond A MacDougald; Ming You; Bart O Williams; Kun-Liang Guan
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

7.  The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila.

Authors:  Barry J Thompson; Stephen M Cohen
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

8.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

Authors:  H Tamemoto; T Kadowaki; K Tobe; T Yagi; H Sakura; T Hayakawa; Y Terauchi; K Ueki; Y Kaburagi; S Satoh
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

9.  Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia.

Authors:  J C Martinou; M Dubois-Dauphin; J K Staple; I Rodriguez; H Frankowski; M Missotten; P Albertini; D Talabot; S Catsicas; C Pietra
Journal:  Neuron       Date:  1994-10       Impact factor: 17.173

10.  Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.

Authors:  J Kunz; R Henriquez; U Schneider; M Deuter-Reinhard; N R Movva; M N Hall
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

View more
  88 in total

1.  BAF chromatin remodeling complex: cortical size regulation and beyond.

Authors:  Tran Cong Tuoc; Ramanathan Narayanan; Anastassia Stoykova
Journal:  Cell Cycle       Date:  2013-08-13       Impact factor: 4.534

2.  RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.

Authors:  Hao Yin; Roman L Bogorad; Carmen Barnes; Stephen Walsh; Iris Zhuang; Hidenori Nonaka; Vera Ruda; Satya Kuchimanchi; Lubomir Nechev; Akin Akinc; Wen Xue; Marino Zerial; Robert Langer; Daniel G Anderson; Victor Koteliansky
Journal:  J Hepatol       Date:  2015-11-30       Impact factor: 25.083

Review 3.  Organ-Size Regulation in Mammals.

Authors:  Alfredo I Penzo-Méndez; Ben Z Stanger
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-07-17       Impact factor: 10.005

4.  The Hippo pathway effector Yki downregulates Wg signaling to promote retinal differentiation in the Drosophila eye.

Authors:  Erika Wittkorn; Ankita Sarkar; Kristine Garcia; Madhuri Kango-Singh; Amit Singh
Journal:  Development       Date:  2015-05-14       Impact factor: 6.868

5.  Hippo-YAP and mTOR pathways collaborate to regulate organ size.

Authors:  Alfred Csibi; John Blenis
Journal:  Nat Cell Biol       Date:  2012-12       Impact factor: 28.824

6.  Brk regulates wing disc growth in part via repression of Myc expression.

Authors:  Nikolaos Doumpas; Marina Ruiz-Romero; Enrique Blanco; Bruce Edgar; Montserrat Corominas; Aurelio A Teleman
Journal:  EMBO Rep       Date:  2013-01-22       Impact factor: 8.807

Review 7.  The Hippo pathway: regulators and regulations.

Authors:  Fa-Xing Yu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2013-02-15       Impact factor: 11.361

8.  The Hippo-YAP signaling pathway and contact inhibition of growth.

Authors:  Barry M Gumbiner; Nam-Gyun Kim
Journal:  J Cell Sci       Date:  2014-02-15       Impact factor: 5.285

9.  G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.

Authors:  Laura Regué; Fan Mou; Joseph Avruch
Journal:  Bioessays       Date:  2013-03-01       Impact factor: 4.345

10.  YAP is up-regulated in the bronchial airway smooth muscle of the chronic asthma mouse model.

Authors:  Jing Zhou; Fei Xu; Jing Jing Yu; Wei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.